DESCRIBE <http://purl.uniprot.org/citations/1864962>

Subject	Predicate	Object
http://purl.uniprot.org/citations/1864962	http://purl.uniprot.org/core/volume	"88"xsd:string
http://purl.uniprot.org/citations/1864962	http://purl.uniprot.org/core/name	"J. Clin. Invest."xsd:string
http://purl.uniprot.org/citations/1864962	http://xmlns.com/foaf/0.1/primaryTopicOf	https://pubmed.ncbi.nlm.nih.gov/1864962
http://purl.uniprot.org/citations/1864962	http://purl.uniprot.org/core/author	"Wu D.-A."xsd:string
http://purl.uniprot.org/citations/1864962	http://purl.uniprot.org/core/author	"Chung B.-C."xsd:string
http://purl.uniprot.org/citations/1864962	http://purl.uniprot.org/core/date	"1991"xsd:gYear
http://purl.uniprot.org/citations/1864962	http://purl.uniprot.org/core/title	"Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively."xsd:string
http://purl.uniprot.org/uniprot/P08686	http://purl.uniprot.org/core/citation	http://purl.uniprot.org/citations/1864962
http://purl.uniprot.org/citations/1864962	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/1864962	http://www.w3.org/2004/02/skos/core#exactMatch	http://purl.uniprot.org/pubmed/1864962
http://purl.uniprot.org/uniprot/P08686#attribution-0C85A6523714180E18514C00EB981497	http://purl.uniprot.org/core/source	http://purl.uniprot.org/citations/1864962
http://purl.uniprot.org/citations/1864962	http://purl.uniprot.org/core/pages	"519-523"xsd:string
http://purl.uniprot.org/citations/1864962	http://purl.org/dc/terms/identifier	"doi:10.1172/jci115334"xsd:string
http://purl.uniprot.org/uniprot/#_P08686-citation-1864962	http://www.w3.org/1999/02/22-rdf-syntax-ns#object	http://purl.uniprot.org/citations/1864962